Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Metaplasia × Endoscopy × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urogenital Neoplasms 1 Upper Tract Urothelial Carcinoma 1 Stomach Neoplasms 1 Metaplasia 1 Lung Neoplasms 1 Gastroesophageal Reflux 1 Colitis 1 Carcinoma, Non-Small-Cell Lung 1 Barrett Esophagus 1

Interventions

Erlotinib Hydrochloride 1 Endoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04454476 2024-07-31

Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor

Vanderbilt-Ingram Cancer Center

Phase 1 Active not recruiting

Gastrointestinal

Metaplasia, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡